| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/20/2008 | EP1889907A1 Novel amino group transferase, gene encoding the same and method of using the same |
| 02/20/2008 | EP1889906A1 High-copy-number, high-expression vector having methionine aminopeptidase gene therein |
| 02/20/2008 | EP1889905A1 Method for amelioration of disease condition induced by mood disorder |
| 02/20/2008 | EP1889902A1 Method for transformation using mutant acetolactate synthase gene |
| 02/20/2008 | EP1889058A1 Diagnosis and treatment of endometriosis |
| 02/20/2008 | EP1888782A2 Modulation of stat 6 expression for the treatment of airway hyperresponsiveness |
| 02/20/2008 | EP1888763A2 Mannitol induced promoter systems in bacterial host cells |
| 02/20/2008 | EP1888761A2 Recombinant n-glycosylated proteins from procaryotic cells |
| 02/20/2008 | EP1888758A2 Transduction of primary cells |
| 02/20/2008 | EP1888757A2 Methods and products for determining f4/80 gene expression in microglial cells |
| 02/20/2008 | EP1888756A2 Nucleic acid molecules encoding echi-like polypeptides and methods of use |
| 02/20/2008 | EP1888755A2 Means and methods to modulate flavonoid biosynthesis in plants and plant cells |
| 02/20/2008 | EP1888754A1 Promoter for epidermis-specific, pathogen-inducible transgenic expression in plants |
| 02/20/2008 | EP1888753A1 Penicillium capsulatum arabinofuranosidase |
| 02/20/2008 | EP1888752A2 Hepatitis c virus vaccine |
| 02/20/2008 | EP1888751A2 A hepatitis c virus non-structural ns3/4a fusion gene |
| 02/20/2008 | EP1888750A1 Shrna and sirna expression in a living organism under control op a codon-optimized tetracycline repressor gene |
| 02/20/2008 | EP1888749A1 Oligonucleotides for rna interference and biological applications thereof |
| 02/20/2008 | EP1888748A2 Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (tina) and process for the preparation of tina |
| 02/20/2008 | EP1888747A2 Rna interference induction element and use thereof |
| 02/20/2008 | EP1888746A2 Ordered multi-step synthesis by nucleic acid-mediated chemistry |
| 02/20/2008 | EP1888745A2 Dna fragments, primers and method for amplification of the dna fragments and kit including the aforementioned primers for the detection and identification of clinically relevant candida species |
| 02/20/2008 | EP1888744A2 A process comprising codon optimization for the production of recombinant activated human protein c for the treatment of sepsis |
| 02/20/2008 | EP1888646A2 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants |
| 02/20/2008 | EP1888638A2 Method of producing antibodies with modified fucosylation level |
| 02/20/2008 | EP1888632A2 Cytokine |
| 02/20/2008 | EP1888625A2 Malaria vaccines |
| 02/20/2008 | EP1888622A1 Compositions for inducing an immune response against hepatitis b |
| 02/20/2008 | EP1888114A2 Anti- mcp-1 antibodies, compositions, methods and uses |
| 02/20/2008 | EP1888108A2 Silicibacter sp. strain useful for genetic transformation of marine algae and production of antibiotic agents |
| 02/20/2008 | EP1888052A2 Blockade of pin1 prevents cytokine production by activated immune cells |
| 02/20/2008 | EP1808070A8 Animal model of neurodegenerative diseases, method of obtaining same and uses thereof |
| 02/20/2008 | EP1789441A4 Notch mutations leading to increased receptor signaling |
| 02/20/2008 | EP1784489A4 Linear dna fragment for markerless deletion, novel strain having inhibited formation of biofilm and preparation method thereof |
| 02/20/2008 | EP1766054A4 Compositions and methods |
| 02/20/2008 | EP1713911A4 Probe set and method for identifying hla allele |
| 02/20/2008 | EP1558741B1 Recombination of nucleic acid library members |
| 02/20/2008 | EP1492891B1 Methods of virus production |
| 02/20/2008 | EP1458867B1 Gene promoters |
| 02/20/2008 | EP1430156B1 Apparatus regulating nucleotide release during a reaction |
| 02/20/2008 | EP1419235A4 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 02/20/2008 | EP1406667B1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 02/20/2008 | EP1399585B1 Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2) |
| 02/20/2008 | EP1385370B1 Animicrobial polypeptides and their uses |
| 02/20/2008 | EP1330474B1 Diagnostic use of a specific co-activator for human nuclear receptors |
| 02/20/2008 | EP1257670B1 Method for detecting cytosine methylation in dna samples |
| 02/20/2008 | EP1243651B1 Method of detecting sexual differentiation disruptor |
| 02/20/2008 | EP1242821B1 Direct screening method |
| 02/20/2008 | EP1177211B1 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease |
| 02/20/2008 | EP1163349B1 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 02/20/2008 | EP1154791B1 Neisserial vaccine compositions and methods |
| 02/20/2008 | EP1121437B1 Metastatic breast and colon cancer regulated genes |
| 02/20/2008 | EP1109935B1 Two-colour differential display, used as a method for detecting regulated genes |
| 02/20/2008 | EP1100922B1 Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine |
| 02/20/2008 | EP1099759B1 Vibrio cholerae vaccine candidates and methods of their constructing |
| 02/20/2008 | EP1012324B1 Promiscuous g-protein compositions and their use |
| 02/20/2008 | EP1007672B1 Intracellular glucocorticoid-induced leucine zippers modulators of apoptic cell death pathways |
| 02/20/2008 | EP0985039B1 Artificial antibody polypeptides |
| 02/20/2008 | EP0975745B1 Extracellular expression of cellulose binding domains (cbd) using bacillus |
| 02/20/2008 | EP0970966B1 Fungal antigens and process for producing the same |
| 02/20/2008 | EP0918872B1 A method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 02/20/2008 | EP0907746B1 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis |
| 02/20/2008 | EP0846186B1 Extraction, amplification and sequential hybridisation of fungus cell dna and a process for detecting fungus cells in clinical material |
| 02/20/2008 | EP0837687B1 Hapten modified tumor cell extract and methods of treating cancer |
| 02/20/2008 | EP0731806B2 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF |
| 02/20/2008 | EP0689551B1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 02/20/2008 | CN101128603A Signal amplification method |
| 02/20/2008 | CN101128601A Methods of amplifying and sequencing nucleic acids |
| 02/20/2008 | CN101128598A Methods of producing influenza vaccine compositions |
| 02/20/2008 | CN101128593A Method for reversing multiple resistance in animal cells |
| 02/20/2008 | CN101128592A Gene delivery system containing decorin gene and pharmaceutical composition for treating cancer containing the system |
| 02/20/2008 | CN101128591A Expression cassettes for seed-preferential expression in plants |
| 02/20/2008 | CN101128590A Plants having increased yield and method for making the same |
| 02/20/2008 | CN101128589A Plants having increased yield and method for making the same |
| 02/20/2008 | CN101128588A Enhanced zein reduction in transgenic corn seed |
| 02/20/2008 | CN101128587A Gene expression technique |
| 02/20/2008 | CN101128586A Methods for producing soluble membrane-spanning proteins |
| 02/20/2008 | CN101128585A Recombinant production of serum albumin |
| 02/20/2008 | CN101128584A New modified gene of anthranilic acid synthase gene OASA2 of rice and use of the same |
| 02/20/2008 | CN101128583A Enzymatic production of glycolic acid |
| 02/20/2008 | CN101128582A Assist probes and method of using the same |
| 02/20/2008 | CN101128581A Mutant aox 1 promoters |
| 02/20/2008 | CN101128580A Enzymes for starch processing |
| 02/20/2008 | CN101128579A α-淀粉酶变体 α- amylase variants |
| 02/20/2008 | CN101128578A Method of inducing differentiation of skeletal muscle cell |
| 02/20/2008 | CN101128577A Recombinant microorganisms for increased production of organic acids |
| 02/20/2008 | CN101128483A Antibodies directed to angiopoietin-2 and uses thereof |
| 02/20/2008 | CN101128479A Novel plasmid autonomously replicable in enterobacteriaceae family |
| 02/20/2008 | CN101128475A Delta15 desaturases suitable for altering levels of polyunsaturated fatty acids in oilseed plants and oleaginous yeast |
| 02/20/2008 | CN101128192A Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level |
| 02/20/2008 | CN101128182A Heavy chain and domain antibodies |
| 02/20/2008 | CN101126106A Gastric cancer auxiliary diagnosis gene order and application thereof |
| 02/20/2008 | CN101126100A Tumour bi-target adenovirus AdCN103 and its construction method and application |
| 02/20/2008 | CN101126099A Method for conversing aspergillus fumigatus and special-purpose expression carrier for the same |
| 02/20/2008 | CN101126098A Small disturbance RNA molecule expression carrier for differentially inhibiting GFAP protein expression and its construction method and use thereof |
| 02/20/2008 | CN101126097A Glutamine transaminase zymogen gene for streptomyces hygroscopicus and expression thereof |
| 02/20/2008 | CN101126096A Firefly luciferase gene and application thereof |
| 02/20/2008 | CN101126095A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101126094A Genetic immunization with nonstructural proteins of hepatitis c virus |
| 02/20/2008 | CN101126093A Bacillus thuringiensis insecticidal crystal protein gene and application |